%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
% KOMA-Script Presentation
% LaTeX Template
% Version 1.1 (18/10/15)
%
% This template has been downloaded from:
% http://www.LaTeXTemplates.com
%
% Original Authors:
% Marius Hofert (marius.hofert@math.ethz.ch)
% Markus Kohm (komascript@gmx.info)
% Described in the PracTeX Journal, 2010, No. 2
%
% License:
% CC BY-NC-SA 3.0 (http://creativecommons.org/licenses/by-nc-sa/3.0/)
%
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%

%----------------------------------------------------------------------------------------
%	PACKAGES AND OTHER DOCUMENT CONFIGURATIONS
%----------------------------------------------------------------------------------------
% KOMA-Script_MDPI_jpm-1309345
% compiling only on TexLive 2019

\documentclass[
paper=landscape,
paper=160mm:90mm, %128mm:96mm, % The same paper size as used in the beamer class
fontsize=11pt, % Font size
pagesize, % Write page size to dvi or pdf
parskip=half-, % Paragraphs separated by half a line
%captions=tableheading
]{scrartcl} % KOMA script (article)

\linespread{1.12} % Increase line spacing for readability



%~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
% from main.tex
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% Tex
\maxdeadcycles=1000 % Output loop---200 consecutive dead cycles.

% http://mirror.ox.ac.uk/sites/ctan.org/macros/latex/contrib/biblatex/doc/biblatex.pdf it is compatible with KOMA-script
%\usepackage[backend=biber, style=authoryear, sorting=nyt, natbib=false]{biblatex}
% ****** backend=bibtex *******
\usepackage[backend=bibtex, style=authoryear]{biblatex}
%\bibliography{TCGA_margin_cutoff.bib, betel.bib, TMSB4X.bib, pvalueTex.bib}
% ~\autocite{}
\addbibresource{TCGA_margin_cutoff}
\addbibresource{betel.bib}
\addbibresource{TMSB4X.bib}
\addbibresource{pvalueTex.bib}
\addbibresource{Deep_Learning.bib}
% for citep
%\usepackage[comma,authoryear,square]{natbib} 
%\setcitestyle{authoryear,open={[},close={]}}
%\PassOptionsToPackage{comma,authoryear,square}{natbib}

\usepackage{wrapfig} % for wrapfigure, text wrapping figure

\usepackage{todonotes}

\usepackage{floatrow} % for side caption (beside)
%\floatsetup[widefigure]{margins=hangleft,capposition=beside,capbesideposition={center,outside},floatwidth=\textwidth} % {center,outside}
\usepackage{amsmath,amsfonts}
\usepackage{tikz-imagelabels} % for  tikz
\usepackage[bf]{caption}
\newcommand{\bcaption}[2]{\caption{\textbf{#1} #2}}

\usepackage{outlines}

\usepackage{pgfgantt} % for Gantt chart/flow chart
\definecolor{barblue}{RGB}{153,204,254}
\definecolor{groupblue}{RGB}{51,102,254}
\definecolor{linkred}{RGB}{165,0,33}

\usepackage{newfloat} % for caption of smartdiagram
\DeclareFloatingEnvironment[fileext=diag,placement={!ht},name=Figure ]{diag} % diag

\usepackage{smartdiagram} %flowchart
\usesmartdiagramlibrary{additions} 
\usepackage{tikz}   % for DAG plot by  tikzpicture
\usetikzlibrary{arrows}
\input{arrowsnew}

%\usepackage[]{caption} % bf
%\newcommand{\bcaption}[2]{\caption{\textbf{#1} #2}}
%\usepackage{outlines}
% mark in blue or red
%\usepackage{xcolor}

%\usepackage{xr-hyper}
%\usepackage{hyperref}
%\newcommand{\R}[1]{\label{#1}\linelabel{#1}} % for \label page and line
%\newcommand{\R}[1]{\linelabel{#1}} % for \label page and line
%\newcommand{\lr}[1]{page~\pageref{#1} (line~\lineref{#1})} % for \ref page and line
% for xr in your preamble
% https://www.overleaf.com/learn/how-to/Cross_referencing_with_the_xr_package_in_Overleaf
%\makeatletter
%\newcommand*{\addFileDependency}[1]{% argument=file name and extension
%  \typeout{(#1)}
%  \@addtofilelist{#1}
%  \IfFileExists{#1}{}{\typeout{No file #1.}}
%}
%\makeatother

%\newcommand*{\myexternaldocument}[1]{%
%    \externaldocument{#1}%
%    \addFileDependency{#1.tex}%
%    \addFileDependency{#1.aux}%
%}
% my external document I would like to reference the labels of. 
%\myexternaldocument{Supplementary_figures} %.tex .aux


%% not tikz
%\usepackage{pstricks-add}
%\usepackage{pst-all} % for PSTricks
%\usepackage{pst-plot,pst-eucl}
%\psset{algebraic,saveNodeCoors}

%\def\f{x+.5}
%\def\g{y-.5}% inverse of \f
%https://tex.stackexchange.com/questions/120788/draw-line-from-a-point-to-another-line-along-x-axis-or-y-axis-in-tikz/120817
%%
\usepackage{array}
\usepackage{ragged2e}
\usepackage{rotating}
\usepackage{tabularx} % for resizebox?
\usepackage{makecell}
% \usepackage{array}
\usepackage{multirow}
\usepackage{colortbl}     % arrayrulecolor
% \usepackage{colortbl}
\usepackage{longtable}

\usepackage{hhline}
%\usepackage{soul} % for \hl{}
\usepackage{siunitx} % for  1e-10 scientific notation, \num
%\usepackage{caption}
%\usepackage{subcaption}
%\usepackage{subcaption} % for figure  side by side, subfigure

%DIF 140a141
\usepackage{pbox} %DIF > 
%DIF -------

\usepackage{booktabs, multirow} % for borders and merged ranges
\usepackage{soul}% for underlines
%\usepackage[table]{xcolor} % for cell colors
\usepackage{changepage,threeparttable} 

%%% for abbreviations, or acronyms
\usepackage[acronym, nopostdot]{glossaries}  % automake
\usepackage{glossary-inline}
%\setacronymstyle{long-short}
%\renewcommand*{\glossarysection}[2][]{} 
%\renewcommand*{\glossarysection}[2][]{\textbf{#1}: }
% for abbreviations environment
%\newcommand{\abbrlabel}[1]{\makebox[3cm][l]{\textbf{#1}\ \dotfill}}
\newenvironment{abbreviation}


%\section{abbreviation}
%%%%%%%%%%%%% Define abbreviation
%\makeglossaries %https://tex.stackexchange.com/questions/110095/list-of-acronyms-is-not-displayed
\newacronym{hrv}{HRV}{heart rate variability}
\newacronym{ovh}{OVH}{oral verrucous hyperplasia}

\newacronym{tmuh}{TMUH}{Taipei Medical University Hospital}
\newacronym{tmu}{TMU}{Taipei Medical University}
\newacronym{tmwh}{TMWH}{Taipei Municipal Wan-Fang Hospital}

\newacronym{cnn}{CNN}{Convolutional Neural Network}
\newacronym{gnn}{GNN}{Graph Neural Network}
\newacronym{gcnn}{GCNN}{Graph Convolutional Neural Network}
\newacronym{rnn}{RNN}{Recurrent Neural Network}
\newacronym{ehr}{EHR}{electric healthcare records}


\newacronym{ptta}{PTTA}{p value of t-test or ANOVA}
\newacronym{anova}{ANOVA}{analysis of variance}
\newacronym{lcms}{LC-MS/MS}{liquid chromatography with tandem mass spectrometry}
\newacronym{maldi}{MALDI MS}{matrix-assisted laser desorption/ionization mass spectrometry}
\newacronym{maldii}{MALDI IMS}{matrix-assisted laser desorption/ionization imaging mass spectrometry}


\newacronym{ncbi}{NCBI}{National Center for Biotechnology Information}
\newacronym{degs}{DEGs}{differentially expressed genes}

\newacronym{ihc}{IHC}{immunohistochemistry}
\newacronym{fdr}{FDR}{false discovery rate}

\newacronym{hpa}{HPA}{the Human Protein Atlas}
\newacronym{hnscc}{HNSCC}{head and neck squamous cell carcinoma}
\newacronym{tcga}{TCGA}{the Cancer Genome Atlas}
\newacronym{tcpa}{TCPA}{the Cancer Proteome Atlas}
\newacronym{rna}{RNA}{ribonucleic acid}
\newacronym{rnaseq}{RNA-Seq}{RNA sequencing}
\newacronym{lncrna}{lncRNA}{long non-coding RNA}
%\newacronym{km}{KM}{Kaplan--Meier}
\newacronym{rppa}{RPPAs}{reverse-phase protein arrays}
\newacronym{rpma}{RPMA}{reverse-phase protein lysate microarray}

\newacronym{mmp}{MMP}{matrix metalloproteinase}
 %DKK1, CAMK2N1, STC2, PGK1, SURF4, USP10, NDFIP1, FOXA2, STIP1, and DKC1
 %ZNF557, ZNF266, IL19, MYO1H, FCGBP, LOC148709, EVPLL, PNMA5, KIAA1683, and NPB

\newacronym{DKK1}{DKK1}{dickkopf WNT signaling pathway inhibitor 1} 
\newacronym{CAMK2N1}{CAMK2N1}{calcium/calmodulin dependent protein kinase II inhibitor 1} 
\newacronym{CALML5}{CALML5}{calmodulin like 5}

\newacronym{STC2}{STC2}{stanniocalcin 2} 
\newacronym{PGK1}{PGK1}{phosphoglycerate kinase 1} 
\newacronym{SURF4}{SURF4}{surfeit 4} 
\newacronym{USP10}{USP10}{ubiquitin specific peptidase 10} 
\newacronym{NEDD4}{NEDD4}{neural precursor cell expressed, developmentally down-regulated 4}
\newacronym{NDFIP1}{NDFIP1}{NEDD4 family interacting protein 1} 
\newacronym{FOXA2}{FOXA2}{forkhead box A2} 
\newacronym{STIP1}{STIP1}{stress-induced-phosphoprotein 1} 
\newacronym{DKC1}{DKC1}{dyskeratosis congenita 1, dyskerin} 

\newacronym{ZNF557}{ZNF557}{zinc finger protein 557} 
\newacronym{ZNF266}{ZNF266}{zinc finger protein 266} 
\newacronym{IL19}{IL19}{interleukin 19} 
\newacronym{MYO1H}{MYO1H}{myosin 1H} 
\newacronym{FCGBP}{FCGBP}{Fc fragment of IgG binding protein} 
\newacronym{LOC148709}{LOC148709}{LncRNA LOC148709} 
\newacronym{EVPLL}{EVPLL}{envoplakin-like protein} 
\newacronym{PNMA5}{PNMA5}{paraneoplastic antigen like 5} 
%\newacronym{KIAA1683}{KIAA1683}{IQCN, IQ Motif Containing N} 
\newacronym{IQCN}{IQCN}{IQ motif containing N} % previous name KIAA1683
% "IQ'' refers to the first two amino acids of the motif: isoleucine (commonly) and glutamine (invariably)
\newacronym{NPB}{NPB}{neuropeptide B} 

 \newacronym{rt}{RT}{radiation therapy}
 \newacronym{nccn}{NCCN}{National Comprehensive Cancer Network}
 \newacronym{hif}{HIF}{hypoxia-inducible factor}
 \newacronym{egfr}{EGFR}{epidermal growth factor receptor}
 \newacronym{ras}{RAS}{rat sarcoma}
 \newacronym{hras}{HRAS}{Harvey rat sarcoma viral oncoprotein}
 \newacronym{erk}{ERK}{extracellular signal-regulated kinases}
 \newacronym{us}{US}{United States}
 \newacronym{fda}{FDA}{Food and Drug Administration}
 \newacronym{tpf}{Tax-PF}{docetaxel, cisplatin, and 5-fluorouracil}
 \newacronym{tki}{TKI}{tyrosine kinase inhibitor}
 \newacronym{her}{HER}{human epidermal growth factor receptor}
 \newacronym{ici}{ICI}{immune-checkpoint inhibitor}
 \newacronym{ctla4}{CTLA-4}{cytotoxic T lymphocyte antigen 4}
 \newacronym{pd1}{PD-1}{programmed death 1}
 \newacronym{pdl1}{PD-L1}{programmed death ligand 1}
 \newacronym{tim3}{TIM-3}{T-cell immunoglobulin mucin protein 3}
 \newacronym{lag3}{LAG-3}{lymphocyte activation gene 3}
 \newacronym{ifng}{IFN-$\gamma$}{interferon gamma}
 \newacronym{tigit}{TIGIT}{T cell immunoglobin and immunoreceptor tyrosine-based inhibitory motif}
 \newacronym{gitr}{GITR}{glucocorticoid-induced tumor necrosis factor receptor}
 \newacronym{vista}{VISTA}{V-domain Ig suppressor of T-cell activation}
 \newacronym{tmsb4x}{TMSB4X}{thymosin beta-4 X-linked}
 \newacronym{emt}{EMT}{epithelial-mesenchymal-transition}
 \newacronym{gdc}{GDC}{Genomic Data Commons}
 \newacronym{nci}{NCI}{the National Cancer Institute}
 \newacronym{gdac}{GDAC}{genome data analysis center}
 \newacronym{rest}{REST}{Representational State Transfer} 
 \newacronym{api}{API}{application programmable interface}
\newacronym{grch38}{GRCh38}{Genome Reference Consortium Homo sapiens genome assembly 38}
\newacronym{fpkm}{FPKM}{Fragments per kilobase per million reads mapped}
\newacronym{rsem}{RSEM}{RNA-Seq by Expectation-Maximization}
\newacronym{slca}{SLC35E2A}{solute carrier family 35 member E2A}
\newacronym{slcb}{SLC35E2B}{solute carrier family 35 member E2B}
\newacronym{cde}{CDE}{Common Data Element}
\newacronym{id}{ID}{identification}
\newacronym{ajcc}{AJCC}{the American Joint Committee on Cancer}
\newacronym{uicc}{UICC}{he Union for International Cancer Control}
\newacronym{tnm}{TNM}{the tumor size (T), cervical lymph node metastases (N), and distal metastasis status (M)}
\newacronym{ci95}{95\% CI}{95\% confidence interval}
\newacronym{os}{OS}{overall survival}
\newacronym{hr}{HR}{hazard ratio}
\newacronym{hpv}{HPV}{human papillomavirus}
\newacronym{ene}{ENE}{extra-nodal extension}
\newacronym{lvsi}{LVSI}{lymph-vascular space invasion}
\newacronym{pni}{PNI}{perineural invasion}
\newacronym{doi}{DOI}{depth of invasion}
\newacronym{lnd}{LND}{lymph node density}
\newacronym{wpoi5}{WPOI-5}{worst pattern of invasion score 5}
\newacronym{glut4}{GLUT4}{glucose transporter 4}
\newacronym{slc2a4}{SLC2A4}{solute carrier family 2 member A4}
\newacronym{trim24}{TRIM24}{tripartite motif-containing 24}
\newacronym{til}{TIL}{tumor-infiltrating lymphocytes}
\newacronym{tmb}{TMB}{tumor mutational burden}




%------------------------------------------------
\usepackage{outlines}
\usepackage[font={small}]{caption}
\newcommand{\bcaption}[2]{\caption{\textbf{#1} #2}}


\usepackage[margincaption]{sidecap}

\usepackage{subcaption} % for figure  side by side, subfigure

%%%%%% updated 2020 by esdd
%% https://tex.stackexchange.com/questions/547723/latex-throws-errors-on-section
%------------------------------------------------
% Colors
\usepackage[]{xcolor}  % table % Required for custom colors
% Define a few colors for making text stand out within the presentation
\definecolor{mygreen}{RGB}{44,85,17}
\definecolor{myblue}{RGB}{34,31,217}
\definecolor{mybrown}{RGB}{194,164,113}
\definecolor{myred}{RGB}{255,66,56}
% Use these colors within the presentation by enclosing text in the commands below

\newcommand*{\mygreen}[1]{\textcolor{mygreen}{#1}}
\newcommand*{\myblue}[1]{\textcolor{myblue}{#1}}
\newcommand*{\mybrown}[1]{\textcolor{mybrown}{#1}}
\newcommand*{\myred}[1]{\textcolor{myred}{#1}}

\definecolor{asparagus}{rgb}{0.53, 0.66, 0.42}

\newenvironment{MyColorPar}[1]{% for RED marked of revision
    \leavevmode\color{#1}\ignorespaces%
}{%
}%


% Margins
\usepackage[ % Page margins settings
  includeheadfoot,
  top=-1mm,
  bottom=1.5mm,
  left=1mm,
  right=3.5mm,
  headsep=0mm,
  footskip=8.5mm
]{geometry}

% Fonts
\usepackage[T1]{fontenc}     % For correct hyphenation and T1 encoding
\usepackage{lmodern} % Default font: latin modern font
%\usepackage{fourier} % Alternative font: utopia
%\usepackage{charter} % Alternative font: low-resolution roman font
\renewcommand{\familydefault}{\sfdefault} % Sans serif - this may need to be commented to see the alternative fonts

% Various required packages
\usepackage{amsthm} % Required for theorem environments
\usepackage{bm} % Required for bold math symbols (used in the footer of the slides)
\usepackage{tikz} % Required for colored boxes, loads graphicx and other packages
\usepackage{booktabs} % Required for horizontal rules in tables
\usepackage{multicol} % Required for creating multiple columns in slides
\usepackage{lastpage} % For printing the total number of pages at the bottom of each slide

\usepackage{microtype} % Better typography

% Slide layout configuration
\usepackage[automark]{scrlayer-scrpage} % Required for customization of the header and footer
\clearpairofpagestyles % Remove the default header and footer
\AddLayersAtBeginOfPageStyle{scrheadings}{headerbg,footerbg}% add background layers
\setkomafont{pageheadfoot}{\normalfont\sffamily} % Font settings for the header and footer
\setkomafont{pagehead}{\color{white}}
% Header configuration - if you don't want a header remove this block
\DeclareNewLayer[
  background,
  head,
  hoffset=0pt,
  width=\paperwidth,
  mode=picture,
  contents=\putLL{\myblue{\rule{\layerwidth}{\layerheight}}}
]{headerbg}

\ihead{\rightbotmark}

% Footer configuration
\KOMAoptions{footwidth=\textwidth+2mm:0pt}
\setkomafont{pagefoot}{\color{black}\tiny} % Small font size for the footnote
%\DeclareNewLayer[
  %background,
  %foot,
  %hoffset=0pt,
  %width=\paperwidth,
  %mode=picture,
  %contents=\putLL{\myblue{\rule{\layerwidth}{\layerheight}}}
%]{footerbg}
\ifoot{\runninghead~(OMS)\ \raisebox{0.2mm}{$\bm{\vert}$}\ \myuni} % Left side text
\ofoot*{\myauthor} % Right side;  %\myauthor\ % \pagemark/\pageref{LastPage}

% Sets vertical centering of slide contents with increased space between paragraphs/lists
\makeatletter
\renewcommand*{\@textbottom}{\vskip \z@ \@plus 1fil}
\newcommand*{\@texttop}{\vskip \z@ \@plus .5fil}
\setparsizes{1em}{\z@\@plus .25fil}{0pt plus 1fil}
\makeatother

% Remove page numbers and the dots leading to them from the outline slide
\DeclareTOCStyleEntries[linefill=\hfill,pagenumberbox=\gobble]{section}{section,subsection,subsubsection}
%\newcommand*\gobble[1]{}
\AfterTOCHead{\small}

%\renewcaptionname{english}{\contentsname}{Outline} % contentsname % Change the name of the table of contents
% Section spacing - deeper section titles are given less space due to lesser importance
\RedeclareSectionCommands[beforeskip=0pt,afterskip=0pt,afterindent=true,runin=false]{section,subsection,subsubsection}
\RedeclareSectionCommand[afterskip=-1mm]{subsection}
\RedeclareSectionCommand[afterskip=-2mm]{subsubsection}
\setcounter{secnumdepth}{\partnumdepth} % How deep sections are numbered

% Theorem style
\newtheoremstyle{mythmstyle} % Defines a new theorem style used in this template
  {0.5em} % Space above
  {0.5em} % Space below
  {} % Body font
  {} % Indent amount
  {\sffamily\bfseries} % Head font
  {} % Punctuation after head
  {\newline} % Space after head
  {\thmname{#1}\ \thmnote{(#3)}} % Head spec

\theoremstyle{mythmstyle} % Change the default style of the theorem to the one defined above
\newtheorem{theorem}{Theorem}[section] % Label for theorems
\newtheorem{remark}[theorem]{Remark} % Label for remarks
\newtheorem{algorithm}[theorem]{Algorithm} % Label for algorithms


% The code for the box which can be used to highlight an element of a slide (such as a theorem)
\newcommand*{\mybox}[2]{% The box takes two arguments: width and content
  \par\noindent
  \begin{tikzpicture}[mynodestyle/.style={rectangle,draw=myblue,thick,inner sep=2mm,text justified,top color=white,bottom color=white,above}]
    \node[mynodestyle,at={(0.5*#1+2mm+0.4pt,0)}]{% Box formatting
      \begin{minipage}[t]{#1}
      #2
      \end{minipage}%
    };
  \end{tikzpicture}
\par\vspace{-1.3em}}

%----------------------------------------------------------------------------------------
%	PRESENTER INFORMATION Tex Chi
%----------------------------------------------------------------------------------------
\usepackage{mfirstuc}
\MFUnocap{and}
\MFUnocap{for}
\MFUnocap{in}
\MFUnocap{at}
\MFUnocap{the}
% dissertation title: \title{\capitalisewords{global transcriptomics and proteomics analyses for biomarker identification and validation in head and neck squamous cell carcinoma}}
\newcommand*{\mytitle}{\capitalisewords{English conversation at the Oral and Maxillofacial Surgery Clinic}}
%\newcommand*{\mytitle}{\capitalisewords{global transcriptomics and proteomics analyses for biomarker identification and validation in head and neck squamous cell carcinoma}}
%\newcommand*{\mytitle}{Global Proteomics-based Identification and Validation of Thymosin Beta-4 X-Linked as a Prognostic Marker for Head and Neck Squamous Cell Carcinoma} % old Title Transcriptomic Analysis for Prognostic Value in Head and Neck Squamous Cell Carcinoma
\newcommand*{\runninghead}{Vocabulary}
%Deep Learning} % Running head displayed on almost all slides
\newcommand*{\myauthor}{Li-Hsing (Tex) Chi} % Presenters name(s)
\newcommand*{\myauthorWu}{Chia-Yu Wu}
\newcommand*{\myadvisorM}{Michael Hsiao}
\newcommand*{\myadvisorJ}{Yu-Chuan (Jack) Li}
\newcommand*{\myadvisorA}{Alexander TH Wu}
\newcommand*{\mydate}{2022/04/07} % \today Presentation date {2021/09/10} or {2021/12/10}
\newcommand*{\myuni}{Taipei Medical University} % University or department

\newcommand{\comm}[1]{} % for comment it out; https://tex.stackexchange.com/questions/17816/commenting-out-large-sections
%----------------------------------------------------------------------------------------

\begin{document}


%----------------------------------------------------------------------------------------
%	TITLE SLIDE
%----------------------------------------------------------------------------------------

% Title slide - you may have to tweak a few of the numbers if you wish to make changes to the layout
\thispagestyle{empty} % No slide header and footer

\includegraphics[width=6.5cm]{TMU_SOH_Logo.png}
%TMU_PTM_logo.png}
\begin{tikzpicture}[remember picture,overlay] % Background box
  \node [xshift=\paperwidth/2,yshift=\paperheight/2] at (current page.south west)
    [rectangle,fill,inner sep=0pt,minimum width=\paperwidth,minimum height=\paperheight/1.85,top color=myblue,bottom color=myblue]{}; % Change the height of the box, its colors and position on the page here
\end{tikzpicture}
% Text within the box
\begin{flushright}
%  \vspace{0.45cm}
  \color{white}\sffamily
  {\bfseries\Large\mytitle\par}% Title
  \vspace{0.2cm}
  \normalsize
%  \myauthorWu, DDS, Ph.D.  \hspace{10mm} \par 
 \underline{\myauthor}, DDS, Ph.D.  \hspace{10mm} \par % Author name
%  Advisors: \myadvisorM \hspace{1mm} \myadvisorJ\par \hspace{1mm} \myadvisorA\par
  \mydate %\par % Date
%  \myuni\par
%  \vfill
\end{flushright}
%Chi, L.-H., Wu, A. T. H., Hsiao, M. \& Li, Y.-C. (Jack). Journal of Personalized Medicine, 11, 782 (2021).
%\autocite{Chi2021}
%  \vspace{0.3cm}

\large \hspace{5cm} 
\textcolor{white}{$\longrightarrow$ 
Textbook: "Dental Terminology" \footnotesize{(\url{shorturl.at/iqG18})}
}
%A Holistic Way for Cancer Care

\clearpage

%\begin{figure}
%    \centering
%    \includegraphics[width=13cm]{Article_Banner_TMSB4X_2017.pdf}
%    \caption{Caption}
%    \label{fig:my_label}
%\end{figure}
%\clearpage
%----------------------------------------------------------------------------------------
%	TABLE OF CONTENTS
%----------------------------------------------------------------------------------------

\thispagestyle{empty} % No slide header and footer

\small\tableofcontents % Change the font size and print the table of contents - it may be useful to shrink the font size further if the presentation is full of sections
% To exclude sections/subsections from the table of contents, put an asterisk after \(sub)section like so: \section*{Section Name}
%\clearpage


\textbf{KEYWORD}\\
%head and neck squamous cell carcinoma (HNSCC);\\
%the Cancer Genome Atlas (TCGA); \\
\hl{transcriptomics};\hl{proteomics}; \\
\hl{RNA-seq}; \hl{mass spectrometry};\\
Cox's survival analysis; \hl{optimal cutoff} for Kaplan--Meier curve; \\
%effect size; hazard ratio in Cox's modeling;\\
%\acrfull{tmsb4x}; \\
%\acrfull{CALML5}; \\
%\acrfull{FCGBP}; \\
\hl{holistic cancer care}; mindfulness meditation.

\clearpage

%----------------------------------------------------------------------------------------
%	PRESENTATION SLIDES
%----------------------------------------------------------------------------------------

%\section*{Vize}

%\clearpage

%------------------------------------------------
%\pagestyle{plain}
\section{Dentistry}
\includegraphics[width=14cm]{TMU_IRP_Wu_workflow.png}

\section{Oral and Maxillofacial Surgery}

We, the oral and maxillofacial surgeons, are highly qualified professionals who research, diagnose, interview, treat, and care for patients suffering diseases of the head and neck.

\begin{tikzpicture}[remember picture,overlay] % Background box
  \node [xshift=\paperwidth/2,yshift=\paperheight/2.25] at (current page.south west)
    [rectangle,fill,inner sep=0pt,minimum width=\paperwidth,minimum height=\paperheight/2.35,top color=myblue,bottom color=myblue]{}; % Change the height of the box, its colors and position on the page here
\end{tikzpicture}

\includegraphics[width=13cm]{TAOMS_LOGO.png}

\clearpage
%%
\section{Vocabulary by Parts} % 4

\subsection{Instrumentation Related to Oral Surgery}

\clearpage
%%
\subsection{Surgical Procedures Involved in Exodontia (or odontectomy)}

\clearpage
%%
\subsection{Procedures Involved in Soft-tissue Surgery}

\clearpage
%%
\subsection{Procedures Involved in Minor Bone Surgery}

\clearpage
%%
\subsection{Surgical Procedures Involved in Fracture Repair}

\clearpage
%%
\subsection{Procedures Involved in Maxillofacial Surgery}

An example: Head and Neck Cancer

Oral verrucous hyperplasia (\acrshort{ovh}) is a premalignant exophytic oral mucosal lesion with a predominantly verrucous or papillary surface; this lesion can subsequently transform into verrucous carcinoma (VC), a well-established warty variant of squamous cell carcinoma (SCC).

In \acrshort{ovh}, a predictive biomarker gives early alarm of its malignant transformation, which prevents unnecessary biopsy repeatedly.

%%%%%
\thispagestyle{headings}
\markright{Introduction\hfill Oral cancer is a major disease in Taiwan \hfill}
%\begin{figure}
%\end{figure}



\begin{minipage}[c]{0.60\linewidth}
\begin{outline}
    \1 Head and neck squamous cell carcinoma (HNSCC) in Taiwan, which is:
        \2 derived from the \hl{oral cavity}, oropharynx, hypopharynx and larynx;
        \2 caused by long-term habits of betel nut \hl{[*OR 28.2]}, cigarette [*OR 18.0], alcohol [*OR 10.2]~\autocite{Ko1995}. {\tiny (*odds ratio)}
    \1  HNSCC is a serious problem in Taiwan:
%        \2 The \hl{sixth} common cancer worldwide~\autocite{Siegel2016};
        \2 The age-standardized incidence rate of \acrshort{hnscc} in males is \hl{42.15} per 100,000 person-years~ (7,400 victims/year) ~\autocite{MOHWincidence2018}**;
%        \2 Specialist of otolaryngology, oral and maxillofacial surgery in Taiwan (2021): 2,557 and 431, respectively  
        \2 The \hl{fourth} leading cause of cancer-related death for males in Taiwan (2,779 persons/year)~\autocite{MOHWdeath2017}**.
        {\tiny (*MOHW: Ministry of Health and Welfare, Taiwan)}
\end{outline}
\end{minipage}%\hspace{2mm}
%\begin{wrapfigure}{r}{0.3\textwidth}
\begin{minipage}[c]{0.35\linewidth}
    \raggedright
    \hfill
    \includegraphics[width=4.5cm]{20369933_1755313531164078_5705495585669958017_o.jpg}\\
    %\caption*{
   \tiny (Photo courtesy of Health Promotion Administration, MOHW, Taiwan.)

\end{minipage}




\clearpage

%%%%%%%%%%%
\thispagestyle{headings}
\markright{Introduction\hfill Biomarker-guided HNSCC therapy \hfill}

%The advantages of applying the TCGA data for cancer biomarker identification include:
\begin{outline}
\1  Treatment for HNSCC: \textcolor{green}{surgery}, radiotherapy, or systemic therapy (chemotherapy/targeted therapy)
%There are many physical and social features of patients available for survival modeling. % ($X_1 ... X_n$)
    \2 \hl{metastasis}: from oral cavity (T*) $\longrightarrow$ neck lymph nodes (N*) $\longrightarrow$ the rest of body (M*) (e.g., lung, liver, bone)
    \2 "Biomarkers" guide the treatment after surgery:
%\1 many achievements and getting published, including \hl{Chi} et al., 2021~\autocite{Chi2021}.
%    \2 diagnostic, \textcolor{red}{predictive} or \textcolor{green}{prognostic} biomarkers:
        \3 pathological marker: \textcolor{red}{\acrfull{doi}} ($> 3 mm$), \textcolor{red}{positive surgical margin} ($< 2 mm$) or \textcolor{red}{positive lymph node (N+)} $\longrightarrow$ adjuvant radiation therapy %\hfill {\tiny (* DOI: \acrlong{doi})} is NOT tumor thickness
        \3 molecular marker: over-expression of \textcolor{red}{EGFR} $\longrightarrow$ targeted inhibitor---cetuximab~\autocite{LeTourneau2007} \hfill {\tiny (covered by Taiwan's National Health Insurance since \hl{2009})}
        % \cite{LeTourneau2007} Leblanc2020
        
        {\tiny (* cancer staging by TNM system: \textcolor{red}{T}umor size/depth, neck \textcolor{red}{N}odal metastasis, distant \textcolor{red}{M}etastasis; \\
        TNM system: the Union for International Cancer Control, UICC, and
        the American Joint Committee on Cancer, AJCC)}
\clearpage

%    \2 "The results published~\autocite{Chi2021} and shown here are in part based upon data generated by the TCGA Research Network: \url{https://www.cancer.gov/tcga}."
\1 50\% recurrent rate (on primary or neck) (all stages, global)~\autocite{Forastiere2001,Warnakulasuriya2009}

\1 However, the \hl{survival} rate in Taiwan (2008 $\longrightarrow$ 2018):
    \2 the one-year survival rate*: 79.56\% $\longrightarrow$ 81.62\% (all stages)
    \2 the five-year survival rate*: 55.13\% $\longrightarrow$ 56.03\% (all stages) \\
    {\tiny * \url{https://cris.hpa.gov.tw/pagepub/Home.aspx}}
\1 We do our best ...
\includegraphics[width=4cm]{stationary_survival_Artwork 2.jpg}


\clearpage


%%
\1 We do
    \2 encourage patients for \hl{correction} of their life style;
    \2 \textcolor{green}{wider excision} (T+N) and better free-flap \textcolor{green}{reconstruction}.
%    \2 to find more useful \textcolor{red}{biomarkers}
\end{outline}
\begin{figure}
    \centering
\includegraphics[width=3.5cm]{SOHND_Artwork.jpg}
\end{figure}



\clearpage

%%%%%%%%%%%
\thispagestyle{headings}
\markright{Introduction\hfill We do HNSCC therapy \hfill}

\includegraphics[width=2cm]{IMG_7174.jpg}
\includegraphics[width=4cm]{IMG_6430.jpg} % PET/CT scan
%\begin{figure}[!h]
%    \centering
%    \caption*{(Image courtesy of Guatacara et al., 2018)}
\includegraphics[width=4cm]{Figure-5-Vascular-anatomy-of-ALT-flap-Guatacara-et-al-2018_W640.jpg}\\
\large Wide excision (cut on black line) with selected neck (lymph nodes) dissection\\
\hspace{2cm} 
{\tiny (The illustration courtesy of Guatacara et al., 2018) \par}


% https://www.researchgate.net/publication/337208414_Anterolateral_thigh_versus_radial_forearm_free_flaps_in_reconstruction_of_oral_cavity_malignant_defects/figures?lo=1
%\end{figure}
\includegraphics[width=5cm]{IMG_6791.jpg}
\includegraphics[width=6cm]{IMG_6910.jpg}\\
\large Reconstruction with free flap (tissue transfer) under micro-surgery team\\
{\tiny (Photos courtesy of TMU team: Dr. CY Wu and Dr. Evienne Hong on 2021/11/17)}

\clearpage
%% f/u 2009 to 2021 our thinking process: biomarker, screening TCGA, deep learning and holistic
\thispagestyle{headings}
\markright{Introduction\hfill We do HNSCC research \hfill}

\large Since surgery, we follow patients up closely, and they are always \hl{anxious} about their \hl{recurrence} (so do I).\vspace{5mm}

\begin{outline}
\0 The ways we do for improving our confidence of their prognosis, by
\1 biomarkers discovery from \hl{(A) proteomics} and \hl{(B) transcriptomics} research:
    \2 (A) the in-house HNSCC datasets (in vitro, in vivo)~\parencite{Chi2017};
    \2 (B) the public \acrfull{rnaseq} databases (in silico)~\autocite{Chi2021};
\1 investigation of \hl{surgical margin} (T) and \hl{neck metastasis} (N) by deep learning algorithm (grant proposal);
\1 development of \hl{holistic} cancer care in Taipei Medical University affiliated Hospitals.

\end{outline}
\clearpage
%%

\subsection{Oral Surgery Procedures Involved with TMJ Dysfunction}

\clearpage
%%
\subsection{Surgical Procedures Involved in Dental Implantology}

\clearpage
%%
\subsection{Oral Surgery Role in Esthetic Dentistry}


\clearpage

%

%%
%%% Chi2017 %%%%%%%%%%%%%%%

%%% Chi2021 %%%%%%%%%%%%%%%
\clearpage
\section{The origin of pvalueTex (Chi2021)}

\includegraphics[width=10cm]{KM_plotter2021.jpg}\\
We are looking for biomarker candidates on KM plotter---a GUI-based web tool.\\
{\tiny \url{http://kmplot.com/analysis/index.php?p=service&cancer=pancancer_rnaseq}\\
GUI: graphic user interface, by mouse and click}

\clearpage
%

%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%% table 1
\clearpage
%
\thispagestyle{headings}
\markright{Results\hfill Overall survival of CAMK2N1  \hfill}

%\begin{table}[H] 
%\centering
%\captionsetup{labelformat=empty}
%\captionabove{}
%\end{table}

%\subsection{Future Directions in Translational Medicine}


%\subsubsection*{Proteomics Validation}


%\subsubsection*{Laboratory Validation}


%\subsubsection*{Cancer Type-Agnostic Study}


\section{Summary of Modern HNSCC Therapy}

\thispagestyle{headings}
\markright{Discussion \hfill Poor survival rate of HNSCC patients \hfill}

\begin{minipage}[c]{0.40\linewidth}
\begin{outline}
\0
\0 Despite the improvements in surgery and systemic therapy,
%        \2 the survival of \acrshort{hnscc} has not improved; %worldwide~\autocite{hpa2019};
        \1 the five-year survival rate is under \hl{60\%} in TCGA;
        \1 the five-year survival rate* in Taiwan: \hl{55.13\% $\longrightarrow$ 56.03\%}  (2008-2018).
\0 To find more \hl{unknown pieces of a puzzle} $\longrightarrow$ survival.
\end{outline}

    {\tiny *\url{https://cris.hpa.gov.tw/pagepub/Home.aspx}}
\end{minipage}%\hspace{2mm}
%\begin{wrapfigure}{r}{0.3\textwidth}
\begin{minipage}[c]{0.55\linewidth}
    \raggedright
    \hfill\includegraphics[width=7cm]{KMplot_CAMK2N1.pdf}
\end{minipage}




\clearpage
%%%%%%%%%%%%%%%%%%%%%


\section{Holistic Cancer Care} 

\thispagestyle{headings}
\markright{Introduction \hfill Holistic cancer care \hfill}

Holistic (whole) care: to care \hl{spirit}, \hl{emotion}, \hl{the body} of a person, and his \hl{social} relation.

It is the unknown piece of the puzzle in cancer care.\\
%Deep learning and holistic cancer care in the future: Chi2022
\includegraphics[width=4cm]{piece.jpg}
%%%%%%%%%%%%%%%%%%%%
%%%%%% carcinogenesis

%\comm{ % comment it out

\begin{figure}[ht]

\begin{minipage}[c]{0.50\linewidth}
%\floatbox[{\capbeside\thisfloatsetup{capbesideposition={right,center},capbesidewidth=.25\linewidth,capbesidesep=quad}}]{figure}[\FBwidth]
%\centering

\setlength{\unitlength}{.78cm}
\begin{picture}(20, 10)(0,0) %(1,0.55038404)%
%\centering
  \put(0,0){\includegraphics[width=9.0cm]{Figure_5_holisticCare.pdf}}%
  \put(0.4, 9.3){\fontfamily{qcr}\selectfont
  \textbf{[Physician]}}%
  \put(4.0, 9.3){\fontfamily{qcr}\selectfont
  \textbf{[Patient]}}%
  \put(6.0, 7.8){\fontfamily{qcr}\selectfont
  \small OVH }
\end{picture}
%\includegraphics[width=10cm]{Figure_5_holisticCare.pdf}
\end{minipage}
\hfill
\begin{minipage}[c]{0.40\linewidth}
%{\caption{
%The concept of holistic care for \acrshort{hnscc} patients. %MDPI: please confirm if the extra lines and frame need to be deleted.

Carcinogenesis:\\
\hl{The mind--brain--body axis}~\autocite{Hsiao2012}
\small
\begin{outline}
\1 \hl{stress} %ful environment(giant \textcolor{black}{black} arrow) 
will trigger an emotional response in mind
\1 brain releases stress hormones and \hl{inflammation signals} in cells% in response to negative emotions.
\1 %The  body's internal environment (cells) 
altering epigenetic control in \hl{gene regulation} %and mRNA/miRNA expression %of cells
%Over a long time, the tissue/cells will be transformed into dysplasia and then 
\1 Oral verrucous hyperplasia (OVH) -> \hl{transforming} to HNSCC
%\1 carcinogenesis~\autocite{Lutgendorf2010,Powell2013,Iftikhar2021} with help from other known carcinogens
\end{outline}

\end{minipage}

%%%\label{fig:figure5}
\end{figure}
\clearpage

%} % end of \comm
%%%%%%%%%%%%% care
\comm{ % comment it out
\begin{figure}[ht]

\begin{minipage}[c]{0.50\linewidth}
%\floatbox[{\capbeside\thisfloatsetup{capbesideposition={right,center},capbesidewidth=.25\linewidth,capbesidesep=quad}}]{figure}[\FBwidth]
%\centering

\setlength{\unitlength}{.78cm}
\begin{picture}(20, 10)(0,0) %(1,0.55038404)%
%\centering
  \put(0,0){\includegraphics[width=9.0cm]{Figure_5_holisticCare.pdf}}%
  \put(0.4, 9.3){\fontfamily{qcr}\selectfont
  \textbf{[Physician]}}%
  \put(4.0, 9.3){\fontfamily{qcr}\selectfont
  \textbf{[Patient]}}%
  \put(6.0, 7.8){\fontfamily{qcr}\selectfont
  HNSCC}
\end{picture}
%\includegraphics[width=10cm]{Figure_5_holisticCare.pdf}
\end{minipage}
\hfill
\begin{minipage}[c]{0.45\linewidth}
%Holistic cancer care~\autocite{Mehta2019,Iftikhar2021}:

\small
\begin{outline}
\1 to give the \textcolor{green}{physical care}: surgery and/or systemic therapy (drug)
%\1 to support cancer patients' spiritual, emotional, physical, and socioeconomic needs

\1 \textcolor{green}{therapeutic relationship (TR)}~\autocite{Rogers1979}
    \2 the physicians' spiritual properties \hl{(empathy, sympathy, and compassion)} $\longrightarrow$ cancer patients
    \2 $\longrightarrow$ their \hl{self-compassion} $\longrightarrow$ \hl{resilience} $\longrightarrow$ their mind--brain--body axis $\longrightarrow$ the disease~\autocite{Hsiao2012}
\1 to reduce pain, to promote \hl{survival} from cancer

\end{outline}

\end{minipage}

%%%\label{fig:figure5}
\end{figure}
\clearpage
} % end of comment out

%%%%%%%%%%%%%%%%% 2022/02/12
%%SP3
%{\large Subproject Title: Deep Learning Platform of Depression Analysis with Holistic Healthcare to Predict Malignant Transformation of Oral Verrucous Hyperplasia}\\

%\noindent{\rule{\textwidth}{0.4pt}}
    
%This is brief summary of the contents of the exam
	
%This exam contains \numpages\ pages (including this cover page) and \numquestions\ questions.  The total number of  possible points is \numpoints.

% from Tex's Ph.D. dissertation [Chi2022]:
%According to the National Comprehensive Cancer Network (NCCN) guidelines (Version 3.2021~\citep{Pfister2021}), the current treatment of \acrfull{hnscc} should include of surgery alone, radiation therapy alone, or a combination of the two with adjuvant chemotherapy.
%Despite advancements in these therapies, the five-year survival rate for this disease has only marginally improved over the previous decade, and recurrent disease is seen in up to 50\% of all patients~\citep{Forastiere2001,Warnakulasuriya2009}.
%During 2008 to 2018 in Taiwan, the one-year survival rate for this disease among males is from 79.56\% to 81.62\%~(statistics from Cancer Registry of \acrlong{Thpa}, available at \url{https://cris.hpa.gov.tw/pagepub/Home.aspx}, accessed on August 2021).
%The five-year survival rate for this disease among males ranged from 55.13 percent to 56.03 percent between 2009 and 2014.

%Oral verrucous hyperplasia (\acrshort{ovh}) is a premalignant exophytic oral mucosal lesion with a predominantly verrucous or papillary surface; this lesion can subsequently transform into verrucous carcinoma (VC), a well-established warty variant of squamous cell carcinoma (SCC).

%Biomarkers of cancer have been utilized for diagnostic, predictive or prognostic purposes. 
%A predictive marker helps to select which specific treatment benefits a better survival.
%For example, adjuvant radiation therapy should be done after tumor-ablative surgery in positive surgical margin or metastatic lymph node from the neck dissection. %; it  to select a particular treatment over another.
%It guides to determine which further treatment (e.g., ).
%In \acrshort{ovh}, a predictive biomarker gives early alarm of its malignant transformation, which prevents unnecessary biopsy repeatedly.

%A prognostic marker infers the natural history of disease (survival), which is independent on treatment of choice. Gene-expression based biomarker can indicate a need for further treatment, but does not help to determine which treatment. 
	
	

%%% for figure HE2RNA
\begin{minipage}[c]{0.95\linewidth}
%\smartdiagramset{uniform sequence color=true}
% sequence diagram; flow diagram:horizontal
% 2021
% Figure 5 HE2RNA workflow
\begin{figure}[H]
\centering
%\setcounter{figure}{0}
%\setcounter{diagram}{4}
%\newcounter{diag} % as zero
%\setcounter{diag}{\value{figure}} % for floating environment

%\begin{center}
%\smartdiagram[sequence diagram]{2021/July, Aug, Sep, Oct, Nov, Dec}
\vspace*{30mm}
\smartdiagramset{
    module x sep=3.0cm,
%    module minimum width=3cm,
    text width=2cm,
    back arrow disabled=true,
    border color=none,
    arrow tip=to,
    additions={
additional item bottom color=orange!60!yellow,
   additional item border color=gray,
   additional item shadow=drop shadow,
   additional item offset=0.5cm,
   additional arrow line width=2pt,
   additional arrow tip=to,
   additional arrow color=orange!60!yellow,
    }%,
   %set color list={blue!50!cyan,green!60!lime,orange!50!red,red!80!black},
}

%\smartdiagramset{module x sep=5}
%\smartdiagram[flow diagram:horizontal]{TMU cohort (WSI/EHR), HE2RNA, RNA-Seq}
\smartdiagramadd[flow diagram:horizontal]{
 TMU dataset (WSI), HE2RNA, RNA-Seq (Representation) % module1 2 3
}{
    above of module2/Model (transfer from TCIA) %,
%    below of module3/%Survival Analysis 
} % addition x2
\smartdiagramconnect{to-}{module2/additional-module1}
%\smartdiagramconnect{-to}{module3/additional-module2}

\vspace*{5mm}
\smartdiagramadd[flow diagram:horizontal]{
 TMU dataset (EHR/HRV), \acrshort{rnn}, Survival Analysis
}{}
%\smartdiagramconnect{-to}{module3/module3}
%\begin{tikzpicture}[overlay]  
%\draw[-stealth,line width=1mm,green!40] 
%(module-title3.south) to[out=120,in=-120] (module-title2.north);
%\end{tikzpicture} 

%{
%    above of module2/Model (transfer from TCIA),
%    below of module3/Survival Analysis 
%} % addition x2
%\smartdiagramconnect{to-}{module2/additional-module1}
%\smartdiagramconnect{-to}{module3/additional-module2}
%\vspace*{30mm}
%\smartdiagramset{border color=none, set color list={blue!50!cyan,green!60!lime,orange!50!red,red!80!black}, back arrow disabled=true}

%\smartdiagramset{module x sep=5}
%\smartdiagram[flow diagram:horizontal]{Aim1, Aim2, Aim3}
\end{figure}
\footnotesize 
TCGA: \acrlong{tcga},
TCIA: \acrlong{tcia},
WSI: whole-slide images of pathology,
EHR: \acrlong{ehr}, HRV: \acrlong{hrv},
RNA-Seq: \acrlong{rnaseq},
\acrshort{rnn}: \acrlong{rnn}. 
\end{minipage}
%
%\begin{minipage}[c]{0.45\linewidth}
%\includegraphics[width=14cm]{Figure_HE2RNA.pdf}
%\bcaption{}{} %\captionof{diag} for floating "diag"
%\bcaption{
% ***Workflow of RNA-Seq representation of TMU dataset.
%The deep learning model of HE2RNA, which was trained under TCGA/TCIA \acrshort{hnscc} dataset, could be applied for RNA-Seq prediction of TMU dataset. The representation will be used for subsequent survival analysis.

%} %uncorrected \textit{P} value.}
%\label{fig:HE2RNA}
%\end{minipage}
%\end{center}

%\clearpage

\clearpage

\comm{ % comment out

%\vspace{3em}
%\end{minipage}

% make Figure 6
\begin{figure}[hp]
\centering
\includegraphics[width=10cm]{GCNN_survival.pdf}
\bcaption{Overview of the proposed \acrshort{gcnn} for survival analysis}
{\\We suggest that the TMU dataset should collect "holistic features" in electric healthcare records (EHR), which include physical, pathological, psychological data, and spiritual information. Combined with RNA-Seq representation, whole-slide-images pathology and holistic EHR, the \acrfull{gcnn} should extract high-dimensional information for \acrshort{hnscc} survival prediction.}
\label{fig:GCNN}
\end{figure}


} % end of comment out

\clearpage

%%%%
\section{Results for (SP3)}
\thispagestyle{headings}
\markright{Results \hfill Holistic Cancer Biomarkers \hfill}

\begin{outline}
\1 Discovery of candidate biomarkers to predict the carcinogenesis of HNSCC by TMUH and TMWH datasets.
%2.對於學術研究、國家發展及其他應用方面預期之貢獻
%It will be submitted for further drug development of systemic therapy of HNSCC as personalized medicine.
% 分析\acrshort{tcia}和TMU的癌細胞基因表現量、數位病理影像和全人照護特徵，將有助於驗證候選基因對預後的影響，以發展未來頭頸部鱗狀細胞癌的精準治療計劃。

%\1 EHR
\2 anxiety or depression, serum markers, gene expression

\end{outline}
\clearpage
%%%%%%%%%%%%%


\section*{Conclusions} % 5
\thispagestyle{headings}
\markright{Conclusions \hfill Physical care \hfill}

\begin{outline}

\1 The microenvironment of HNSCC, influenced by the mind--brain--body axis~\autocite{Hsiao2012}
    \2 Four \hl{biomarker} candidates---TMSB4X, CAMK2N1, CALML5, and FCGBP---which are all heavily associated with the prognosis of \acrlong{os}~\autocite{Chi2017, Chi2021};
    \2 TMSB4X might promote metastasis of \hl{neck lymph nodes} (N+);

%    \2 further exploration and understanding using \hl{holistic} multi-parametric approaches
%\1 Good using a placebo effect in HNSCC cancer care
%    \2 dorsolateral prefrontal cortex~\autocite{Carlino2011} is the origin of a placebo effect
%    \2 Confidence/trust (i.e., \hl{TR}) might promote healing through a mind--brain--body connection manner
    

\1 A grant proposal (machine learning algorithm---deep learning)
    \2 CAMK2N1 might involved in positive \textcolor{red}{surgical margin};
%        \2 CAMK2N1 has moderate correlation with N+ (Pearson's r = 0.07) :-)
    \2 CAMK2N1 might predict \textcolor{red}{neck metastasis} in clinical N0 neck before surgery;
\1 A grant proposal for validation of CAMK2N1 by \hl{laboratory experiments}.

\end{outline}

%
\clearpage

\thispagestyle{headings}
\markright{Conclusions \hfill Spiritual care \hfill}

\begin{outline}


%\1 More holistic features in HNSCC dataset
\1 The HNSCC dataset must collect those "\hl{holistic features}" for further \hl{holistic biomarker} in personalized medicine, from
    \2 electric healthcare records (EHR);
    \2 A grant proposal: \hl{wearable device} (heart rate variability, HRV) is correlation with patient's emotional stress $\longrightarrow$ \hl{malignant transformation} of oral lesions (e.g., verrucous hyperplasia);
    %患者配戴 HRV 心率手錶，檢測治療期間，追蹤期間（一年），患者的心理壓力指數（HRV 數字越小表示交感神經越亢奮、壓力指數高）。
    \2 spiritual assessment (the meaning of life, hope, love/be loved, forgive/be forgiven, relationship with the Most High).
    %Thus, we suggest that electric healthcare records (EHR) should include physical, pathological, and psychological data, and even more spiritual information. The \acrshort{tcga} might collect those "holistic features"  (\textcolor{green}{green} dashed line) for further study of personalized medicine.
\1 A \hl{professional spiritual caregiver} 
    \2 \hl{Mindfulness meditation} is helpful to cancer patients
%    \2 confess for not taking care of their bodies and spirits in the past (\hl{causality})
%    \2 give sincere thanks for their physical body's hard work
\end{outline}
\begin{figure}
    \centering
\includegraphics[width=11cm]{family_meeting_Cheung202109.jpg}
\end{figure}

%人俯仰於天地之間
%順從四季氣候變化
%保養正氣陶冶性情
%自我療癒身心靈疾病
%自他不二 心存正念 向內看，解決苦之源
%1.衷心懺悔
%2.真心感謝
%3.誠意祝福
%4.永存善念 慈悲
%5.心無恐懼: 情志養生
%每位醫師都可以成為「創傷知情者」幫助我們身邊的病患，懂他的心靈創傷，讓他有安全感， 才有機會改變疾病的走向
%"每一位患者都有自癒能力， 我們知情之後， 也要逐步讓他本人知情， 看見之後， 在良好的「治療關係」中， 協助他們漸漸找回自己的療癒。（以他們自己的腳步）"
%解說：患者的自癒力就是復原力（resilience),  強調「治療關係」（安全、 信任、 分享權力、 自決） 以及”知情”(暸解過往創傷經驗對自身的影響，進而開始療癒的過程）的重要性。
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%\clearpage
%\thispagestyle{headings}
%\markright{Conclusions \hfill An example of holistic assessment in dental record \hfill}

%\includegraphics[height=6.5cm, width=6.5cm]{Holistic_EHR_TMUH_English.pdf}\hfill
%\includegraphics[height=4.5cm,width=7.5cm]{Holistic_EHR_TMUH_Chinese.pdf}


%\clearpage

%%%%
%\section*{Take Home Message}
%\thispagestyle{headings}
%\markright{Take home message \hfill  \hfill}
%\includegraphics[width=14.5cm]{PCA_CarlRogers.pdf}

\clearpage
%%%%%%%





\section*{Textbook: \\
Dental Terminology \\
Chapter 14: Oral and Maxillofacial Surgery}
% references
\thispagestyle{headings} % No slide header and footer
\markright{References}
%\bibliographystyle{unsrt}
%\bibliography{TCGA_margin_cutoff.bib, betel.bib, TMSB4X.bib, pvalueTex.bib}
%*****
%\printbibliography % for biblatex
%\clearpage

%------------------------------

\includegraphics[width=3cm]{DentalTerminology.png}

\clearpage

%------------------

\thispagestyle{empty} % No slide header and footer

\begin{tikzpicture}[remember picture,overlay] % Background box
  \node [xshift=\paperwidth/2,yshift=\paperheight/2] at (current page.south west)
    [rectangle,fill,inner sep=0pt,minimum width=\paperwidth,minimum height=\paperheight/2.1,top color=myblue,bottom color=myblue]{}; % Change the height of the box, its colors and position on the page here
\end{tikzpicture}
% Text within the box
\begin{flushright}
  \vspace{1.6cm}
  \color{white}\sffamily
  {\bfseries\Large Thanks for your attention \\Comments and suggestions\par}% Title
  \vspace{0.5cm}
  \normalsize
%  \myauthor\par % Author name
%  \mydate\par % Date
  \myuni\par
  \vfill
\end{flushright}



%李友專
%蕭宏昇
%吳駿翃
%王美娟
%楊欣洲
%王皓青
%張資昊
%----------------------------------------------------------------------------------------
%
\end{document}

%%%%%%%%%%%

\begin{figure}
    \centering
%    \includegraphics{}

\begin{ganttchart}[
    bar label node/.style={text width=5cm,align=right,font=\scriptsize\RaggedLeft,anchor=east},
    x unit=0.8cm,
    y unit title=0.4cm,
    y unit chart=0.6cm, %0.5
    vgrid,
    time slot format=isodate-yearmonth, %compress calendar,
    time slot unit=month,
    title/.append style={draw=none, fill=barblue},
    title label font=\sffamily\bfseries\color{white},
    title label node/.append style={below=-1.6ex},
    title left shift=.05,
    title right shift=-.05,
    title height=1,
    bar/.append style={draw=none, fill=groupblue},
    bar height=.6,
    bar label font=\normalsize\color{black!50},
    group right shift=0,
    group top shift=.6,
    group height=.3,
    group peaks height=.2,
    bar incomplete/.append style={fill=green}
   ]{2021-04}{2022-06}
   
   \gantttitlecalendar{year, month}\\ %=name
   \ganttbar[
    progress=100,
    bar progress label font=\small\color{barblue},
    bar progress label node/.append style={right=4pt},
    bar label font=\normalsize\color{barblue},
    name=pp
   ]{Preliminary Biomarker Discovery}{2021-04}{2021-06} \\ % name=pp
   
\ganttset{progress label text={}, link/.style={black, -to}}
% aim1
\ganttgroup{Aim 1}{2021-07}{2021-12} \\
\ganttbar[progress=10, name=T1A]{Process of pathology images}{2021-07}{2021-10} \\
\ganttlinkedbar[progress=0, name=T1B]{Training deep learning model (CNN)}{2021-10}{2021-12} \\

% aim2
\ganttgroup{Aim 2}{2021-07}{2021-12} \\
\ganttbar[progress=2, name=T2A]{\cntext{Biobank specimen linking to EHR data(*)}}{2021-07}{2021-10} \\ % 因Covid-19，臨床研究資料庫獨立作業區2021.05.19暫停服務

\ganttnewline
\ganttlinkedbar[progress=0, name=T2B]{Development of source code (RNN)}{2021-10}{2021-12} \\


\ganttnewline
% aim3
\ganttgroup{Aim 3}{2021-09}{2022-06} \\
  \ganttbar[progress=0, name=T3A]{Development of GCNN $\&$ survival/validation}{2021-09}{2022-06}
  \ganttnewline
%\ganttgroup{Aim 4}{2021-12}{2022-06} \\ %[group top shift =2] to avoid vertically overlap of bars
%  \ganttbar[progress=0]{Analysis of Experimental Data $\&$ Validation}{2021-12}{2022-06}
  % , bar top shift =1.8
  \ganttset{link/.style={green}}
  \ganttlink[link mid=.4]{pp}{T1A}
  \ganttlink[link mid=.159]{pp}{T2A}
  
  \ganttset{link/.style={black}}
  \ganttlink[link mid=.4]{T1B}{T3A}
  \ganttlink[link mid=.159]{T2B}{T3A}
\end{ganttchart}

    \caption{\cntext{Progress}
    \cntext{(*For COVID-19 pandemic in Taiwan, the data workstation is suspended since 2021.05.19)}}
    \label{fig:gantt}
\end{figure}

\clearpage


%%%%
報告親愛的老師，晚安

1）謝謝老師，百忙之中能參加祁力行的口試 （日期時間：2022/01/12 11:00-12:00, Wednesday）；
2）地點（***已變更，不在吳興街），改為「台北市大安區基隆路二段172-1號15樓討論室A」（這是北醫大安校區）。
3）敬請老師填寫「校園訪客登記：數位訪客證」存在手機中即可，
https://glbsys.tmu.edu.tw/guestsign/Apply.aspx
洽公單位請填寫：醫學資訊研究所

4）力行的論文是以口腔癌的治療為骨幹，嵌入 Chi2017 及 Chi2021 兩篇文章，融合改寫、加上deep learning與全人口腔癌照護的概念，總集而成。
博士論文初稿：https://drive.google.com/file/d/1C5iNhcdUzL1LnRiHZ5ZF8LAhZaPMamMB/view?usp=drivesdk

以下為簡介：
Chi2017> 由口腔癌病理檢體，MS mass spectrometry 打碎飛出來的蛋白質片段，來找出生物標記 biomarker (看看什麼基因、蛋白質表現多的，和癌症病患的存活率有關）
發表的文章 https://www.nature.com/articles/s41598-017-09539-w

Chi2021> 則是由口腔癌病理檢體，NGS 基因定序，來找出生物標記 biomarker (看看什麼基因、蛋白質表現多的，和癌症病患的存活率有關）
發表的文章 https://www.mdpi.com/2075-4426/11/8/782/htm；另有video 簡介（十分鐘）
https://encyclopedia.pub/16116

以上報告 麻煩老師了
下週見，謝謝老師
力行敬上
% spared code

%------------------------------------------------

%pstricks

\begin{pspicture}(2008, 0)(2018,100)
\psset{unit=.75cm}
\psaxes[labelFontSize=\scriptstyle]{<->}%
%  (0,0)(2008,0)(2018,100)[$x$-axis,-90][$y$-axis,180]
  \psline[linewidth=1.5pt,
  linecolor=red](2009,55)(2017,57)
\end{pspicture}

\section*{x Verbatim}

How to include a theorem in this presentation:
\begin{verbatim}
\mybox{0.8\textwidth}{
\begin{theorem}[Murphy (1949)]
Anything that can go wrong, will go wrong.
\end{theorem}
}
\end{verbatim}

\clearpage

%------------------------------------------------



\subsection*{Figure}

%\clearfloatsetup{figure}
%\floatsetup[figure]{style=no,capposition=beside,capbesideposition={center,inside},capbesideframe=yes,facing=yes}

\begin{figure}[ht]
\floatbox[{\capbeside\thisfloatsetup{capbesideposition={right,center},capbesidewidth=.35\linewidth,capbesidesep=quad}}]{figure}[\FBwidth]
{\captionsetup{labelformat=empty} \caption{\texttt{capbesidesep=quad}. I want to thank Sonia. The caption can contain any text but needs to describe the image with enough detail for a reader to completely understand the image.}}
{\includegraphics[width=0.6\textwidth]{placeholder.jpg}}
\end{figure}
%\includegraphics[width=9cm]{placeholder}

%\sidecaptionvpos{c}
%\caption{I want to thank Sonia.}
%\end{captionbeside}


\clearpage

%------------------------------------------------

